Advances in medically assisted procreation have transformed the therapeutic landscape
in assisted reproductive technology. This includes in vitro fertilization with a gestational
carrier (GC), traditionally used to treat heterosexual infertile couples for congenital
uterine malformation, acquired conditions including intrauterine adhesions and leiomyoma,
and medical conditions that contraindicate pregnancy. However, the legalization of
same-sex marriage has spurred global demand for medically assisted procreation using
a GC. The United States National Assisted Reproductive Technology Surveillance System
data reported almost 31 000 GC pregnancies between 1999 and 2013
1
; further estimates include a total of >25 000 children born using GCs in India as
of 2012.To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Obstetrics and Gynaecology CanadaAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Trends and outcomes of gestational surrogacy in the United States.Fertil Steril. 2016; 106: 435-442.e2
- ACOG committee opinion no. 660: family building through gestational surrogacy.Obst Gynecol. 2016; 127: e97-e103
- Societal pressures and procreative preferences for gay fathers successfully pursuing parenthood through CIVF and gestational carriers.Reprod Biomed Soc Online. 2019; 9: 1-10
Article info
Publication history
Published online: October 10, 2022
Identification
Copyright
© 2022 The Society of Obstetricians and Gynaecologists of Canada/La Société des obstétriciens et gynécologues du Canada. Published by Elsevier Inc. All rights reserved.
